DEA-HF: The heart failure diuresis efficacy comparison study

11 May 2024 (08:00 - 20:00)

Organised by:

Sign in for access options

Sign in for access options

About the speaker

Doctor Aharon Abbo

Rambam Health Care Campus, Haifa (Israel)

9 More presentations in this session

Presentation thumbnail

A phase 2b, randomised, double-blind, active controlled, multi centre study to evaluate the efficacy, safety and tolerability of oral AZD9977 and dapagliflozin treatment in patients with heart failure

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Discussant review - MIRACLE

Professor M. Packer (Dallas, US)

Presentation thumbnail

A phase 2, randomized, double-blind, placebo-controlled study to assess the tolerability and pharmacodynamic effects of CRD-740, a PDE9 inhibitor, in participants with chronic heart failure

Professor J. Udelson (Boston, US)

Presentation thumbnail

Discussant review - CARDINAL HF

Associate Professor A. Bohm (Bratislava, SK)

Presentation thumbnail

Readily available urinary sodium analysis in patients with acute decompensate Heart Failure

Doctor E. Meekers (Genk, BE)

Access the full session

Session thumbnail

Late breaking clinical trials: medical therapy

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources